Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter
New

Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease

for
Respiratory Syncytial Virus (RSV)
Location: Durham NC, South Euclid OH, Cincinnati OH, Seattle WA
Sponsor: Pfizer

Sex: All

Age: 5 - 17

Code: NCT07839871

Phase 3, Recruiting

A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

for
Secondary Progress Multiple Sclerosis, Multiple Sclerosis
Location: San Diego CA
Sponsor: Immune Response BioPharma, Inc.

Sex: All

Age: 18 - 50

Code: NCT02057159

Phase 2, Phase 3, Recruiting

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

for
Myocarditis, Pericarditis
Location: Ottawa
Sponsor: Ottawa Heart Institute Research Corporation

Sex: All

Age: 5+

Code: NCT05046002

Recruiting

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

for
Healthy Volunteer
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT03878121

Phase 1, Recruiting

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04521764

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge

for
Malaria
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 50

Code: NCT02639299

Recruiting

Vaccine Responses in Patients With B Cell Malignancies

for
Lymphoma
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT05170399

Recruiting

Therapeutic Hepatitis C Virus Vaccine

for
Chronic Hepatitis C Infection
Location: Richmond VA
Sponsor: GeneCure Biotechnologies

Sex: All

Age: 18 - 60

Code: NCT04318379

Phase 1, Recruiting

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

for
Herpes Zoster
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT05580458

Phase 1, Phase 2, Recruiting

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

for
SARS CoV 2 Infection, COVID-19
Location: Brownsville TX, Edinburg TX, Rio Grande City TX
Sponsor: DHR Health Institute for Research and Development

Sex: All

Age: 18+

Code: NCT05279365

Phase 2, Phase 3, Recruiting

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

for
Lymphocytic Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03219450

Phase 1, Recruiting

CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults

for
Diffuse Midline Glioma, H3 K27M-Mutant,
Location: Minneapolis MN
Sponsor: OX2 Therapeutics

Sex: All

Age: 2 - 25

Code: NCT06305910

Phase 1, Recruiting

Conversational Agent Vaccine Promotion RCT

for
Pandemics
Location: Boston MA
Sponsor: Northeastern University

Sex: All

Age: 18+

Code: NCT04884750

Recruiting

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

for
Shingles
Location: Maywood IL
Sponsor: Loyola University

Sex: All

Age: 0+

Code: NCT05554068

Phase 2, Recruiting

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

for
Human Papilloma Virus
Location: Denver CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT04611022

Recruiting

A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

for
COVID-19 Infection
Location: Halifax, Hamilton
Sponsor: McMaster University

Sex: All

Age: 18 - 65

Code: NCT06381739

Phase 2, Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

for
B-Cell Non-Hodgkin Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03017820

Phase 1, Recruiting

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

for
Human Papillomavirus Infection, Vaccination Hesitancy
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT05860725

Recruiting

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

for
Neuroblastoma, High-risk Neuroblastoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT06057948

Phase 2, Recruiting

Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

for
Asplenia
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18 - 65

Code: NCT02232191

Phase 2, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial